Novavax filed for authorization with Health Canada today for its protein-based COVID-19 vaccine. Stanley Erck, President & CEO, Novavax tells BNN Bloomberg that its vaccine can be mixed & matched with others and that it's scaling production globally.
No comments:
Post a Comment
id="blogfeeds"><$BlogFeedsVertical$>
id="postfeeds"><$BlogItemFeedLinks$>